Risk of cancer after use of fertility drugs with in-vitro fertilisation

Lancet

Volumn 354, Issue 9190, 1999, Pages 1586-1590

  Venn, Alison ^a   Watson, Lyndsey ^a   Bruinsma, Fiona ^a   Giles, Graham ^b   Healy, David ^c  

^a LA TROBE UNIVERSITY   (Australia)

^b CANCER EPIDEMIOLOGY CENTRE   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FERTILITY PROMOTING AGENT;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; MORTALITY; OVARY CANCER; PRIORITY JOURNAL; UTERUS CANCER;

EID: 0033530459     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)05203-4     Document Type: Article

References (21)

1. Lambe M., Hsieh C., Trichopoulos D.et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med. 331:1994;5-9.
2. Kroman N., Wohlfahrt J., Andersen K.et al. Time since childbirth and prognosis in primary breast cancer: a population based study. BMJ. 315:1997;851-855.
3. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet. 347:1996;1713-1727.
4. Rossing M., Daling J., Weiss N.et al. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol. 60:1996;3-7.
5. Modan B., Ron E., Lerner-Geva L.et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol. 147:1998;1038-1042.
6. Ricci E., Parrazini F., Negri E.et al. Fertility drugs and the risk of breast cancer. Hum Reprod. 14:1999;1653-1655.
7. Potashnik G., Lerner-Geva L., Genkin L.et al. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril. 71:1999;853-859.
8. Franceshi S., La Vecchia C., Negri E.et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod. 9:1994;1673-1675.
9. La Vecchia C., Negri E., Parazzini F., Franceschi S. Fertility drugs and breast and ovarian cancer. Lancet. 346:1995;1628.
10. Mosgaard B., Lidegaard O., Kjaer S.et al. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril. 67:1997;1005-1012.
11. Whittemore A., Harris R., Intyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies: II, invasive epithelial ovarian cancers in white women. Am J Epidemiol. 136:1992;1184-1203.
12. Rossing M., Daling J., Weiss N.et al. Ovarian tumors in a cohort of infertile women. N Engl J Med. 331:1994;771-776.
13. Shushan A., Paltiel O., Iscovich J.et al. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril. 65:1996;13-18.
14. Venn A., Watson L., Lumley J.et al. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet. 346:1995;995-1000.
15. Rossing M., Weiss N. Fertility drugs and breast and ovarian cancer. Lancet. 346:1995;1627.
16. Venn A., Watson L., Lumley J.et al. Fertility drugs and breast and ovarian cancer. Lancet. 346:1995;1627-1628.
17. MacLachlan V., Besanko M., O'Shea F.et al. A controlled study of the luteinizing hormone-releasing hormone agonist (Buserelin) for the induction of folliculogenesis before in vitro fertilization. N Engl J Med. 320:1989;1233-1236.
18. Kvale G., Heuch I., Ursin G. Reproductive factors and risk of cancer of the uterine corpus: a prospective study. Cancer Res. 48:1988;6217-6221.
19. Harlow B., Weiss N., Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst. 76:1986;399-402.
20. de Mouzon J., Lancaster P. World collaborative report on in vitro fertilization preliminary data for 1995. J Assist Reprod Genet. 14:1997;251S-265S.
21. Sunderstrom I., Ildgruben A., Hogberg U. Treatment-related and treatment-independent deliveries among infertile couples, a long-term follow-up. Acta Obstet Gynecol Scand. 76:1997;238-243.